UB Paderborn / Katalog / Suche / in CDI

Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays

Clinical microbiology and infection, 2010-10, Vol.16 (10), p.1525-1531

2010

Volltextzugriff (PDF)

Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients

Clinical microbiology and infection, 2013-08, Vol.19 (8), p.763-769

2013

Volltextzugriff (PDF)

Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

The New England journal of medicine, 2019-08, Vol.381 (9), p.816-826

2019

Volltextzugriff (PDF)

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries

Journal of antimicrobial chemotherapy, 2024-05, Vol.79 (5), p.1164-1168

2024

Volltextzugriff (PDF)

Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving Highly Antiretroviral Therapy and Monitored With the World Health Organization Public Health Approach in Sub-Saharan Africa and Southeast Asia

Clinical infectious diseases, 2014-01, Vol.58 (1), p.99-109

2014

Volltextzugriff (PDF)

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

The Lancet infectious diseases, 2016-05, Vol.16 (5), p.565-575

2016

Volltextzugriff (PDF)

Field Evaluation of Dried Blood Spots for Routine HIV-1 Viral Load and Drug Resistance Monitoring in Patients Receiving Antiretroviral Therapy in Africa and Asia

Journal of Clinical Microbiology, 2014-02, Vol.52 (2), p.578-586

2014

Volltextzugriff (PDF)

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

Scientific reports, 2024-05, Vol.14 (1), p.10244-10244, Article 10244

2024

Volltextzugriff (PDF)

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2468-2474

2018

Volltextzugriff (PDF)

Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon

Clinical infectious diseases, 2013-08, Vol.57 (4), p.604-607

2013

Volltextzugriff (PDF)

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries

Journal of antimicrobial chemotherapy, 2019-02, Vol.74 (2), p.462-467

2019

Volltextzugriff (PDF)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

AIDS (London), 2015-07, Vol.29 (12), p.1473-1481

2015

Volltextzugriff (PDF)

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients

AIDS (London), 2011-11, Vol.25 (17), p.2183-2188

2011

Volltextzugriff (PDF)

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.577-586

2013

Volltextzugriff (PDF)

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1517-1521

2015

Volltextzugriff (PDF)

Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network

Clinical infectious diseases, 2012-05, Vol.54 (suppl 4), p.S273-S279

2012

Volltextzugriff (PDF)

Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations

AIDS research and human retroviruses, 2012-09, Vol.28 (9), p.1157

2012

Volltextzugriff (PDF)

Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial

Journal of acquired immune deficiency syndromes (1999), 2013-04, Vol.62 (5), p.569

2013

Volltextzugriff (PDF)

Simian immunodeficiency viruses (SIVs) in Africa

Journal of neurovirology, 2005, Vol.11 Suppl 1, p.27-32

2005

Volltextzugriff (PDF)

Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa

AIDS research and human retroviruses, 2005-05, Vol.21 (5), p.430-433

2005

Volltextzugriff (PDF)

Low Levels of Antiretroviral-Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second-Line Treatment

Clinical infectious diseases, 2009-05, Vol.48 (9), p.1318-1322

2009

Volltextzugriff (PDF)

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

PharmacoEconomics - open, 2020-03, Vol.4 (1), p.45-60

2020

Volltextzugriff (PDF)

Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals

PloS one, 2013-01, Vol.8 (1), p.e55225

2013

Volltextzugriff (PDF)

Genetic diversity among human immunodeficiency virus-I non-B subtypes in viral load and drug resistance assays : HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues

Clinical microbiology and infection, 2010, Vol.16 (10), p.1525-1531

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays

Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients

Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries

Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving Highly Antiretroviral Therapy and Monitored With the World Health Organization Public Health Approach in Sub-Saharan Africa and Southeast Asia

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Field Evaluation of Dried Blood Spots for Routine HIV-1 Viral Load and Drug Resistance Monitoring in Patients Receiving Antiretroviral Therapy in Africa and Asia

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey

Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network

Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations

Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial

Simian immunodeficiency viruses (SIVs) in Africa

Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa

Low Levels of Antiretroviral-Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second-Line Treatment

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals

Genetic diversity among human immunodeficiency virus-I non-B subtypes in viral load and drug resistance assays : HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues

Suchergebnisse filtern